OncoTargets and Therapy
Volume 11, 2018 - Issue
Open access
73
Views
17
CrossRef citations to date
0
Altmetric
Original Research
Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
Man Wu1 State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China;2 Department of Pharmacy, The 309th Hospital of PLA, Beijing, China
, Guanren Zhao2 Department of Pharmacy, The 309th Hospital of PLA, Beijing, China
, Xiaomei Zhuang1 State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China
, Tianhong Zhang1 State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China
, Ce Zhang2 Department of Pharmacy, The 309th Hospital of PLA, Beijing, China
, Wenpeng Zhang1 State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, ChinaCorrespondence[email protected] [email protected]
& Zhenqing Zhang1 State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, ChinaCorrespondence[email protected] [email protected]
show all
Pages 2945-2954
|
Published online: 18 May 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.